

Dopamine(DOPE) Price Live Chart
Dopamine(DOPE) price today is $0.001291, with a 24-hour trading volume of $57.49K and as such Dopamine(DOPE) has a market cap of $35.13K, giving it a market dominance of 0.0000046%. The Dopamine(DOPE) price moved +1.73% in the last 24 hours.
DOPE Price Data
- 24h Turnover$57.49K
- All-Time High(ATH)$0.6559
- 24h High$0.001317
- All-Time Low(ATL)$0.0005
- 24h Low$0.00121
DOPE Market Cap Infos
- Market Cap$35.13K
- Fully Diluted Valuation$161.42K
- Market Cap/FDV21.77%
- Market SentimentPositive
DOPE Supply
- Circulating Supply27.2M DOPE
- Total Supply125M DOPE
- Max Supply125M DOPE
Dopamine(DOPE) is predicted to average $0.00129 in 2025, with a potential swing between the lowest price $0.0009422 and the highest price $0.001329. By 2035, Dopamine(DOPE) price could reach to $0.005608, offering a potential +236.00% return from today’s Dopamine price.
Year | Minimum Price | Highest Price | Average Price | Change |
---|---|---|---|---|
2025 | $0.0009422 | $0.001329 | $0.00129 | -- |
2026 | $0.000917 | $0.001938 | $0.00131 | +1.00% |
2027 | $0.001494 | $0.002355 | $0.001624 | +25.00% |
2028 | $0.001193 | $0.002785 | $0.001989 | +54.00% |
2029 | $0.001337 | $0.002793 | $0.002387 | +84.00% |
2030 | $0.00202 | $0.003057 | $0.00259 | +100.00% |
2031 | $0.002626 | $0.003304 | $0.002824 | +118.00% |
2032 | $0.002022 | $0.003493 | $0.003064 | +137.00% |
2033 | $0.002754 | $0.00459 | $0.003278 | +153.00% |
2034 | $0.002872 | $0.00476 | $0.003934 | +204.00% |
2035 | $0.003304 | $0.005608 | $0.004347 | +236.00% |
Dopamine(DOPE) price has moved +1.73% in the last 24 hours, and +8.34% in the past 7 days. The price of Dopamine(DOPE) is +8.08% in the past 30 days, and -89.75%over the last year.
Time period | Change amount | % Change |
---|---|---|
1H | -$0.000001033 | -0.08% |
24H | +$0.00002196 | +1.73% |
7D | +$0.00009941 | +8.34% |
30D | +$0.00009654 | +8.08% |
1Y | -$0.0113 | -89.75% |
About Dopamine (DOPE)
Contract

8kqmghm1m...d3eanwkcd
Explorers
explorer.solana.com
Website
web3intelligence.com
Dopamine (DOPE) Investors


